NCT03297606 2026-03-04
CAPTUR
Canadian Cancer Trials Group
Phase 2 Recruiting
Clinical Trials
15 trialsNCT04626024 2025-12-19
TOKIN
Baylor College of Medicine
Phase 2 Recruiting
NCT03654768 2025-12-18
Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
SWOG Cancer Research Network
Phase 2 Active not recruiting
NCT03831776 2025-06-08
BosuPeg
St. Olavs Hospital
Phase 2 Completed
NCT02810990 2023-02-03
BEST
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2 Completed
NCT03128411 2022-05-19
Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Pfizer
Phase 2 Completed
NCT00880009 2021-09-27
Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer
Pfizer
Phase 2 Terminated
NCT02638467 2020-11-05
Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy
University of Milano Bicocca
Phase 2 Completed
NCT04578847 2020-10-08
READIT
National Research Center for Hematology, Russia
Phase 2 Unknown
NCT02906696 2020-05-11
Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00261846 2017-07-27
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
Pfizer
Phase 2 Completed
NCT03205267 2017-07-02
BODO
University of Bonn
Phase 2 Unknown
NCT01331291 2016-07-25
Bosutinib in Adult Patients With Recurrent Glioblastoma
Massachusetts General Hospital
Phase 2 Completed
NCT00319254 2013-01-31
Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer
Pfizer
Phase 2 Completed
NCT00793546 2012-11-05
Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer
Pfizer
Phase 2 Terminated